Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

164.91
Delayed Data
As of Mar 27
 -0.83 / -0.50%
Today’s Change
133.64
Today|||52-Week Range
184.21
+12.79%
Year-to-Date
The 'Fearless Girl' Statue Isn't a Symbol, It Is an Advertisement
Mar 27 / Zacks.com - Paid Partner Content
Biotech Bull Making a Comeback
Mar 21 / Zacks.com - Paid Partner Content
Amgen's Humira Biosimilar Approved in Europe
Mar 27 / GuruFocus News - Paid Partner Content
Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop
Mar 20 / Zacks.com - Paid Partner Content
J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe
Mar 27 / Zacks.com - Paid Partner Content
Why Biotech Stock Gilead (GILD) Could Be a Value Trap
Mar 20 / Zacks.com - Paid Partner Content
Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma
Mar 27 / Zacks.com - Paid Partner Content
Trumpcare may be healthy for Big Pharma and insurers
Mar 20 / CNNMoney.com
6 Best Stocks for Value Investors This Week
Mar 26 / GuruFocus News - Paid Partner Content
Stock Market News for March 17, 2017
Mar 17 / Zacks.com - Paid Partner Content
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Mar 24 / Zacks.com - Paid Partner Content
What are Sanofi's (SNY) Strengths and Challenges in 2017?
Mar 17 / Zacks.com - Paid Partner Content
Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
Mar 24 / Zacks.com - Paid Partner Content
Amgen to refund cholesterol drug if patients suffer heart attack
Mar 17 / FT.com - Paid Partner Content
Stock Market News for March 24, 2017
Mar 24 / Zacks.com - Paid Partner Content
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China
Mar 16 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Allianc...
Mar 24 / Zacks.com - Paid Partner Content
Does Amgen Offer a Great Value Buying Opportunity Right Now?
Mar 16 / Zacks.com - Paid Partner Content
Stock Research Reports for Amgen, Berkshire & Walgreens
Mar 23 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data
Mar 16 / Zacks.com - Paid Partner Content
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valean...
Mar 22 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Lymphoma Indication
Mar 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
Amgen's Repatha Meets Primary Endpoint in Phase III Study
Mar 14 / Zacks.com - Paid Partner Content
4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
Mar 21 / TheStreet.com - Paid Partner Content
Eczema drug from Regeneron tipped for blockbuster status
Mar 12 / FT.com - Paid Partner Content
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
Trump vows to bring drug prices 'way down'
Mar 07 / CNNMoney.com